This is a StreetInsider.com Premium Only Page

Viking Therapeutics (VKTX) – Hot Corp. News

Feb 27, 2024 04:20 PM Viking Therapeutics (VKTX) Announces $350M Proposed Public Offering of Common Stock

Feb 27, 2024 07:03 AM Viking Therapeutics (VKTX) Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity

May 16, 2023 07:14 AM

Sep 18, 2018 07:08 AM

Dec 7, 2017 05:38 AM

Nov 28, 2017 07:05 AM

Oct 24, 2017 07:07 AM

Oct 23, 2017 07:08 AM

Jul 26, 2016 07:04 AM